Automate data acquisition, monitor trends in real time, and respond to deviations proactively.

We deliver custom assay development, screening, potency, and selectivity testing services for the pharmaceutical, biopharmaceutical, and agrochemical industries.

Evaluating small and large molecule therapeutics within cellular environments is essential to understanding their efficacy, potency, and safety within a complex biological system.

Curia’s DMPK scientists deliver expert solutions for your drug discovery programs. Providing bioanalytical methods development, in vitro ADMET testing and in vivo PK and PD services that span all stages of drug discovery up to candidate selection.

Curia’s expert scientists use advanced technology to produce and analyze high-quality recombinant proteins.

Whether you require a particular expertise or a complete, experienced integrated small molecule discovery team, Curia can provide a high-performance solution to help turn your vision into reality.

For more than 30 years Curia has been meeting the custom synthesis needs of our clients.

Curia’s discovery biology team accelerates your program toward the clinic and commercialization with our best-in-class, customizable solutions.